B+
Bull case
20%
Probability
Target price
$9.38
Analysis reference price unavailable
Analysis 2025-10-10 · RankAlpha Sentiment AI
MGTX
MeiraGTxFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Bull case assumes positive clinical readouts and at least one partnering/licensing deal within three months that materially de-risks programs and accelerates milestones, prompting re-rating versus peers.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
Clinical trial failure or safety signal
Momentum
79
Value
64
Sentiment
6
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $7.33 · Bull $9.38 · Bear $3.52Analysis 2025-10-10; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2025-10-10 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-11
Investment thesis
As of 2026-09-11
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $29.43
Why
Momentum79 · Δ7d -4.0
Value64 · Δ7d -0.0
Sentiment6 · Δ7d +5.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • Clinical trial failure or safety signal
- • Faster-than-expected cash burn requiring dilutive financing
- • Bear case assumes negative or delayed readouts, higher-than-expected cash burn leading to dilution, and no partnership, compressing valuation and liquidity for further R&D.
Catalyst clock
No dated catalyst is available.
Clinical trial readouts for lead gene-therapy programs
Lead driver: Value · See fundamentals
Momentum
79
9% active weight
Current posture
7d trendSoftening
Δ7d
-4.0
Δ21d
-7.6
Value
64
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+15.4
Sentiment
6
62% active weight
Current posture
7d trendImproving
Δ7d
+5.0
Δ21d
+5.7
Why this grade
Composite grade F. Momentum 78.6 / Value 63.9 / Sentiment 5.7
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2025-10-10. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$7.33
Analysis reference price unavailable
Analysis 2025-10-10 · RankAlpha Sentiment AI
B-
Bear case
25%
Probability
Target price
$3.52
Analysis reference price unavailable
Analysis 2025-10-10 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.32B
Beta
1.38
Shares Out
96.04M
P/E (TTM) · Derived
-9.7
P/S (TTM)
22.17
P/FCF (TTM) · Derived
71.31
Rev YoY
+8608.6%
EPS YoY
-455.9%
Gross Margin
+94.9%
Op Margin
+45.9%
Net Debt
$22.76M
Current Ratio
3.76
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data